Results 31 to 40 of about 5,933 (209)

Status epilepticus in patients with juvenile myoclonic epilepsy: Frequency, precipitating factors and outcome [PDF]

, 2021
Status epilepticus (SE) is rarely described in patients with juvenile myoclonic epilepsy (JME), and little is known about its frequency, subtypes, and predictors and the prognosis of these patients.
AYDIN-OZEMIR, Zeynep, GURSES, Candan, Oguz-Akarsu, Emel, Bebek, Nerses, GOKYIGIT, Aysen, Baykan, BETÜL   +5 more
core   +1 more source

Heart rate and conductivity disorders in juvenile myoclonic epilepsy: genetic predictors

Эпилепсия и пароксизмальные состояния, 2021
General practitioners, therapists, and cardiologists do not have formal education (training) regarding cerebrocardial syndrome, primarily heart rhythm and conduction disorders in epilepsy and sudden unexpected death in epilepsy (SUDEP), as well as the ...
N. A. Shnayder, M. M. Petrova, K. V. Petrov, D. V. Dmitrenko, R. F. Nasyrova   +4 more
doaj   +1 more source

Neuropsychology and behavior in juvenile myoclonic epilepsy [PDF]

, 2013
Following decades of neglect, there has been an increasing interest in the behavioral aspects of juvenile myoclonic epilepsy (JME) in the recent literature.
Feucht, Martha, Hermann, Bruce, Yacubian, Elza Márcia Targas [UNIFESP], Schmitz, Bettina, Trimble, Michael   +4 more
core   +1 more source

CHD2 variants are a risk factor for photosensitivity in epilepsy. [PDF]

, 2015
Photosensitivity is a heritable abnormal cortical response to flickering light, manifesting as particular electroencephalographic changes, with or without seizures. Photosensitivity is prominent in a very rare epileptic encephalopathy due to de novo CHD2
Cantonetti, L., Muhle, H., Thiele, H., Lench, N, Krishna Chinthapalli, V, Krause, R, Sadleir, L. G., Gaudio, L.D., Moller, R. S., EURO Epinomics CoGIE Consortium, Afrikanova, T, Jocic-Jakubi, B., Capovilla, G., Myers, C., Myers, C. T., Sadleir, LG, Muhle, H, Nürnberg, P, Helbig, I., Parisi, P., EuroEPINOMICS CoGIE Consortium,, Pendziwiat, M., Stephani, U., Coppola, A., Kasteleijn-Nolst Trenité, D.G.A., Myers, CT, Chinthapalli, V. K., Krishna Chinthapalli, V., Stephani, U, Del Gaudio, L., de Kovel, C.G.F., Scheffer, I.E., De Kovel, CGF, Chinthapalli, VK, Veggiotti, P., Lehesjoki, AE, Jacmin, M., Drury, S., Piccioli, M., Berkovic, S. F., Esguerra, C., Trenite, D., Martins, T.G., Chinthapalli, V., Thiele, H, Kasteleijn-Nolst Trenité, DG, Lehesjoki, A., Crawford, A., Boustred, C., Lerche, H, Moller, R., Galizia, E. C., Ruppert, A. -K., Helbig, I, Schubert, J, Schneider, A. L., Mefford, H.C., Crawford, AD, Schubert, J., Schneider, A.L., Veggotti, P, Esguerra, CV, Striano, S., Ruppert, A., Berkovic, S., Galizia, EC, Cordero-Maldonado, M., Leu, C., Mefford, H. C., Martins, T. G., Palotie, A, Crawford, A. D., Ruppert, A.K., Covanis, A., Sisodiya, S., Ruppert, AK, Cordero-Maldonado, M. L., Møller, RS, Esguerra, C. V., Trenité, D. G. A. K. -N., Schneider, A., Coppola, A, Cantonetti, L, Leu, C, Del Gaudio, L, Cordero-Maldonado, ML, De Kovel, C. G. F., Berkovic, SF, Mullen, S. A., Trenité, DGAKN, Martins, T., Koeleman, BPC, Jacmin, M, Covanis, A, Boustred, C, Moller, RS, Martins, TG, Sisodiya, SM, Koeleman, B., Sander, T, Mullen, S.A., Sander, T., Nürnberg, P., Lehesjoki, A.E., Berkovic, S.F, Sisodiya, S.M., Mullen, SA, Cordero-Maldonado, M.L., Sadleir, L.G., Palotie, A., Pendziwiat, M, Parisi, P, Capovilla, G, Scheffer, I., Koeleman, BP, Gaudio, LD, Lerche, H., Mullen, S., Veggiotti, P, Myers, C.T., Scheffer, I. E., Koeleman, B. P. C., De Kovel, C., Piccioli, M, Esguerra, C.V., Sisodiya, S. M., Lehesjoki, A. -E., Afrikanova, T., de Kovel, CG, Mefford, HC, Koeleman, B.P.C., Drury, S, Scheffer, IE, Galizia, E.C., Schneider, AL, Mefford, H., Møller, R.S., Krause, R., Galizia, E., Crawford, A.D., Striano, S, Jocic-Jakubi, B, Lench, N., Sadleir, L.   +143 more
core   +1 more source

Unmasking of myoclonus by lacosamide in generalized epilepsy

Epilepsy and Behavior Case Reports, 2017
Lacosamide is a new-generation antiseizure medication that is approved for use as an adjunctive treatment and monotherapy in focal epilepsy. Its use in generalized epilepsy, however, has not been adequately evaluated in controlled trials.
Daniel Birnbaum, Mohamad Koubeissi
doaj   +1 more source

Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy [PDF]

, 2021
Purpose: There are conflicting data regarding the drug dose that is sufficient to achieve seizure control as well as the parameters of seizure remission in juvenile myoclonic epilepsy (JME).
Gurer, Reyhan, Aydin, Senay, Ozkara, Cigdem   +2 more
core   +1 more source

Functional connectivity disturbances of ascending reticular activating system and posterior thalamus in juvenile myoclonic epilepsy in relation with photosensitivity: A resting-state fMRI study [PDF]

, 2021
Objective: Juvenile myoclonic epilepsy (JME) is typified by the occurrence of myoclonic seizures after awakening, though another common trait is myoclonic seizures triggered by photic stimulation.
Demiralp, Tamer, Eryürek, Kardelen, Ulaşoglu Yıldız, Çiğdem, Harı, Emre, Bebek, Nerses, Kurt, Elif, Ur Özçelik, Emel, Ay, Ulaş, Baykan, Betül, Şirin, Nermin Görkem   +9 more
core   +1 more source

Thyroxine-Induced Absences in JME

Pediatric Neurology Briefs, 1996
A patient with juvenile myoclonic epilepsy (JME), manifested as absences at age 10 and myoclonic jerking and generalized tonic clonic seizures at age 15, was treated successfully with primidone at the King Fahad National Guard Hospital, Riyadh, Saudi ...
J Gordon Millichap
doaj   +1 more source

Intestinal-Cell Kinase and Juvenile Myoclonic Epilepsy. [PDF]

, 2019
peer reviewedWith regard to the article by Bailey et al. (March 15, 2018, issue) on the potential role of variants in the gene encoding intestinal cell kinase (ICK) in genetic generalized epilepsies, including juvenile myoclonic epilepsy: We attempted ...
BALLING, Rudi, Lowenstein, Daniel H., Epi4K Consortium/Epilepsy Phenome/Genome,, Lerche, Holger, MAY, Patrick, Berkovic, Sam F., KRAUSE, Roland, EpiPGX consortium,, Peter, Sarah, EuroEPINOMICS-CoGIE,, BOBBILI, Dheeraj Reddy   +10 more
core   +1 more source

Juvenile myoclonic epilepsy: Under-diagnosed syndrome [PDF]

, 2011
Introduction. Juvenile myoclonic epilepsy is an idiopathic, hereditary form of epilepsy. Although juvenile myoclonic epilepsy is a well defined clinical syndrome, attempts at diagnosing it commonly fail. Etiopathogenesis.
Ksenija Bozic, Marija Knezevic-Pogancev, Petar Slankamenac, Ksenija Gebauer-Bukurov, Slobodan Sekulic   +4 more
core   +1 more source